COVID-19 vaccines

It is about San Marino, and its victory over the coronavirus can be attributed to the fact that it is not a member of the EU, so it did not have to follow the strict rules of the regulatory bodies of the Union about which vaccines we can use, writes Russia Today.

In an effort to further increase the coverage of its inoculation program, Turkey has lowered the eligibility age for the vaccine against COVID-19 to 16.

Those aged 16 and over are now entitled to make appointments to receive their first doses of the jab.

The World Health Organization said on July 9 that there was a "likely causal association" between coronavirus vaccines using mRNA technology and "very rare" heart inflammations, but the benefits still outweigh the risks.

Interim results from a phase 3 trial in Turkey have shown that two doses of CoronaVac, a vaccine developed by the Chinese firm Sinovac, are 83.5 percent effective against symptomatic COVID-19.

Romania's National COVID-19 Vaccination Coordination Committee (CNCAV) reports that 16,183 doses of vaccine have been administered in the past 24 hours, of which 10,013 doses of Pfizer vaccine, 522 of Moderna vaccine, 217 of AstraZeneca vaccine and 5,431 of Johnson & Johnson vaccine.

In very rare cases following vaccination with the COVID-19 vaccinesComirnaty and Spikevax (previously COVID-19 Vaccine Moderna)

Pfizer is preparing a third booster Covid shot to take on the deadly Delta variant, the company revealed.

The pharma corporation is seeking emergency authorization from the US FDA for another jab to be administered six-to-twelve months after full vaccination.

Pfizer and BioNTech announced on July 8 they would seek authorization for a third dose of their COVID-19 vaccine to boost its efficacy, as the Delta variant drove devastating outbreaks in Asia and Africa and cases rose again in Europe and the United States.

Turkey has begun to administer its national COVID-19 vaccine candidate, TURKOVAC, on volunteers in Istanbul as part of Phase 3 trials.

Jointly developed by the Health Ministry, Health Institutes of Turkey (TUSEB) and Erciyes University, the national inactive candidate vaccine is being administered at the Başakşehir Çam and Sakura City Hospital ahead of wider use.

Romania's National COVID-19 Vaccination Coordination Committee (CNCAV) reports that 16,311 doses of vaccine have been administered in the past 24 hours, of which 9,918 doses of Pfizer vaccine, 552 of Moderna vaccine, 321 of AstraZeneca vaccine and 5,520 of Johnson & Johnson vaccine. CNCAV shows that 9,938 people were vaccinated with the first dose and 6,373 received the second dose.